There is also a lot of information available elsewhere on our website:
Tests and Treatments.
Although the test is currently approved only for Stage IV metastatic bc. There is enough evidence that it is also effective for earlier stages. I understand that Siemens is currently considering petitioning the FDA to approve the test for these patients.
The test costs approximately $300.00 and most insurance companies will pay regardless of stage.
Regards
Joe